|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in/provided by operating activities: | |||||
| Depreciation | |||||
| Write-off of obsolete inventory | |||||
| Realized (gain)/loss on marketable debt and equity securities | |||||
| Bad debt expense | |||||
| Amortization, deferred financing cost | |||||
| Loss on debt extinguishment | |||||
| Interest paid in kind | |||||
| Change in estimated fair value of contingent consideration | |||||
| Deferred income taxes | |||||
| Settlement claim to be paid in shares | |||||
| Shares issued for services | |||||
| Depreciation and amortization expense | |||||
| Right-of-use amortization expense | |||||
| Share based compensation | |||||
| Expenses paid by IDC | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses | |||||
| Unbilled accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Prepaid income taxes | |||||
| Due from related parties | |||||
| Deposits | |||||
| Other assets | |||||
| Right of use assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Due to related parties | |||||
| Income taxes payable | |||||
| Accrued expenses and other current liabilities | |||||
| Contingent consideration liability | |||||
| Operating lease liability | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment, net | |||||
| Purchases of marketable debt securities | |||||
| Maturity of marketable debt securities | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock, gross | |||||
| Payment for issuance costs of common stock | |||||
| Repayments of finance lease liability | |||||
| Borrowings on revolving line of credit | |||||
| Payments on revolving line of credit | |||||
| Borrowings on credit agreement | |||||
| Repayments of Notes Payable | |||||
| Borrowings on other debt | |||||
| Payments on other debt | |||||
| Borrowings on notes payable | |||||
| Deemed capital contribution from recapitalization | |||||
| Debt issuance costs payment | |||||
| Transaction consideration paid on behalf of Parent | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and Cash Equivalents – Beginning of period | |||||
| Cash and Cash Equivalents – End of period | |||||
| Supplemental Disclosures of Cash Flow Information | |||||
| Cash paid during the year for: | |||||
| Interest | |||||
| State Income Taxes, net of refunds received | |||||
| Non-cash investing and financing activities: | |||||
| Fixed assets acquired through finance lease | |||||
| Settlement shares issued to legacy stockholders | |||||
| Derecognition of debt, net related to debt deconsolidation | |||||
| Accretion of redeemable units to redemption value | |||||
| Unpaid interest added to Term Note | |||||
| Unpaid debt issuance costs added to Term Note | |||||
| Notes payable issued for amounts due under contingent consideration arrangements | |||||
| Deemed capital contribution | |||||
| Change in related parties | |||||
| Deemed capital contribution from Merger | |||||
| Liabilities assumed in Merger | |||||
| Recapitalization of equity as a result of the Merger | |||||
Loading...